← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2012Last known activity
Jan 3, 2026
Acquired by Agilent Technologies, Inc. on Jul 27, 2009
Timeline
1940s
- Jun 1, 1948
Varian Medical Systems— Founded
2000s
- Jul 27, 2009
Agilent Technologies, Inc.— Acquired By
2010s
- May 9, 2019
CyberHeart— Acquired
- May 20, 2019
Cancer Treatment Services International— Acquired
- Jun 10, 2019
Endocare— Acquired
Drugs by trial phase (16 distinct, 11 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (11)
- NCT07276360CollaboratorPhase 2Jan 3, 2026
- NCT06858735CollaboratorPhase 2Aug 1, 2025
- NCT06111313CollaboratorPhase 2Mar 1, 2024
- NCT05501665CollaboratorPhase 1/Phase 2Jan 31, 2023
- NCT05560659CollaboratorPhase 2Nov 30, 2022
- NCT04567251CollaboratorPhase 3Jan 31, 2021
- NCT03984357CollaboratorPhase 2Dec 31, 2019
- NCT03718650CollaboratorEarly Phase 1Aug 1, 2019
- NCT03960008CollaboratorPhase 3Jun 30, 2019
- NCT02182687CollaboratorPhase 2Jun 1, 2014
- NCT01752257CollaboratorPhase 1Jul 1, 2012
Details
- Founded
- Palo Alto, CA, US Jun 1, 1948
- Last known activity
- Jan 3, 2026